An exploratory, randomised, parallel-group, open-label, multicentre study to assess the post-operative management of moderate to severe pain in patients who underwent laparoscopic cholecystectomy, receiving oxycodone hydrochloride i.v. within 12 - 24 hours after surgery at first and then oxycodone / naloxone prolonged release tablets compared to patients receiving piritramide infusions.

Trial Profile

An exploratory, randomised, parallel-group, open-label, multicentre study to assess the post-operative management of moderate to severe pain in patients who underwent laparoscopic cholecystectomy, receiving oxycodone hydrochloride i.v. within 12 - 24 hours after surgery at first and then oxycodone / naloxone prolonged release tablets compared to patients receiving piritramide infusions.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Oxycodone (Primary) ; Oxycodone/naloxone (Primary) ; Piritramide (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Mundipharma GmbH
  • Most Recent Events

    • 21 Jul 2012 Janssen-Cilag added as associations as reported in the European Clinical Trials Database record.
    • 21 Jul 2012 Actual initiation date (27 Feb 2009) added as reported by European Clinical Trials Database record.
    • 24 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top